137 related articles for article (PubMed ID: 30476727)
1. abcb1ab p-glycoprotein is involved in the uptake of the novel antidepressant vortioxetine into the brain of mice.
Spieler D; Namendorf C; Namendorf T; Uhr M
J Psychiatr Res; 2019 Feb; 109():48-51. PubMed ID: 30476727
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein differentially affects escitalopram, levomilnacipran, vilazodone and vortioxetine transport at the mouse blood-brain barrier in vivo.
Bundgaard C; Eneberg E; Sánchez C
Neuropharmacology; 2016 Apr; 103():104-11. PubMed ID: 26700248
[TBL] [Abstract][Full Text] [Related]
3. Donepezil, a cholinesterase inhibitor used in Alzheimer's disease therapy, is actively exported out of the brain by abcb1ab p-glycoproteins in mice.
Spieler D; Namendorf C; Namendorf T; von Cube M; Uhr M
J Psychiatr Res; 2020 May; 124():29-33. PubMed ID: 32114029
[TBL] [Abstract][Full Text] [Related]
4. Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption.
Uhr M; Grauer MT; Holsboer F
Biol Psychiatry; 2003 Oct; 54(8):840-6. PubMed ID: 14550684
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls.
Uhr M; Grauer MT; Yassouridis A; Ebinger M
J Psychiatr Res; 2007; 41(1-2):179-88. PubMed ID: 16387324
[TBL] [Abstract][Full Text] [Related]
6. abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice.
Uhr M; Grauer MT
J Psychiatr Res; 2003; 37(3):179-85. PubMed ID: 12650738
[TBL] [Abstract][Full Text] [Related]
7. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.
Cisternino S; Mercier C; Bourasset F; Roux F; Scherrmann JM
Cancer Res; 2004 May; 64(9):3296-301. PubMed ID: 15126373
[TBL] [Abstract][Full Text] [Related]
8. Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier.
Dirson G; Fernandez C; Hindlet P; Roux F; German-Fattal M; Gimenez F; Farinotti R
Pharm Res; 2006 Jul; 23(7):1525-32. PubMed ID: 16779703
[TBL] [Abstract][Full Text] [Related]
9. Effects on enantiomeric drug disposition and open-field behavior after chronic treatment with venlafaxine in the P-glycoprotein knockout mice model.
Karlsson L; Hiemke C; Carlsson B; Josefsson M; Ahlner J; Bengtsson F; Schmitt U; Kugelberg FC
Psychopharmacology (Berl); 2011 May; 215(2):367-77. PubMed ID: 21191569
[TBL] [Abstract][Full Text] [Related]
10. Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings.
O'Brien FE; Dinan TG; Griffin BT; Cryan JF
Br J Pharmacol; 2012 Jan; 165(2):289-312. PubMed ID: 21718296
[TBL] [Abstract][Full Text] [Related]
11. The role of the polymorphic efflux transporter P-glycoprotein on the brain accumulation of d-methylphenidate and d-amphetamine.
Zhu HJ; Wang JS; DeVane CL; Williard RL; Donovan JL; Middaugh LD; Gibson BB; Patrick KS; Markowitz JS
Drug Metab Dispos; 2006 Jul; 34(7):1116-21. PubMed ID: 16621932
[TBL] [Abstract][Full Text] [Related]
12. In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug-drug interactions at the mouse blood-brain barrier.
Cisternino S; Rousselle C; Debray M; Scherrmann JM
Pharm Res; 2004 Aug; 21(8):1382-9. PubMed ID: 15359572
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ABCB1 and ABCG2 at the Mouse Blood-Brain Barrier with Marketed Drugs To Improve Brain Delivery of the Model ABCB1/ABCG2 Substrate [
Traxl A; Mairinger S; Filip T; Sauberer M; Stanek J; Poschner S; Jäger W; Zoufal V; Novarino G; Tournier N; Bauer M; Wanek T; Langer O
Mol Pharm; 2019 Mar; 16(3):1282-1293. PubMed ID: 30694684
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein reduces the ability of amitriptyline metabolites to cross the blood brain barrier in mice after a 10-day administration of amitriptyline.
Grauer MT; Uhr M
J Psychopharmacol; 2004 Mar; 18(1):66-74. PubMed ID: 15107187
[TBL] [Abstract][Full Text] [Related]
15. Interaction of nonpeptidic delta agonists with P-glycoprotein by in situ mouse brain perfusion: liquid chromatography-mass spectrometry analysis and internal standard strategy.
Dagenais C; Ducharme J; Pollack GM
J Pharm Sci; 2002 Jan; 91(1):244-52. PubMed ID: 11782913
[TBL] [Abstract][Full Text] [Related]
16. Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier.
Bihorel S; Camenisch G; Lemaire M; Scherrmann JM
J Neurochem; 2007 Sep; 102(6):1749-1757. PubMed ID: 17696988
[TBL] [Abstract][Full Text] [Related]
17. Involvement of P-glycoprotein and multidrug resistance associated protein 1 in the transport of tanshinone IIB, a primary active diterpenoid quinone from the roots of Salvia miltiorrhiza, across the blood-brain barrier.
Zhou ZW; Chen X; Liang J; Yu XY; Wen JY; Zhou SF
Drug Metab Lett; 2007 Aug; 1(3):205-17. PubMed ID: 19356045
[TBL] [Abstract][Full Text] [Related]
18. Acute Effects of Viral Exposure on P-Glycoprotein Function in the Mouse Fetal Blood-Brain Barrier.
Bloise E; Petropoulos S; Iqbal M; Kostaki A; Ortiga-Carvalho TM; Gibb W; Matthews SG
Cell Physiol Biochem; 2017; 41(3):1044-1050. PubMed ID: 28222448
[TBL] [Abstract][Full Text] [Related]
19. The influence of P-glycoprotein on cerebral and hepatic concentrations of nortriptyline and its metabolites.
Ejsing TB; Hasselstrøm J; Linnet K
Drug Metabol Drug Interact; 2006; 21(3-4):139-62. PubMed ID: 16841511
[TBL] [Abstract][Full Text] [Related]
20. Blood-brain barrier penetration of the enantiomers of venlafaxine and its metabolites in mice lacking P-glycoprotein.
Karlsson L; Schmitt U; Josefsson M; Carlsson B; Ahlner J; Bengtsson F; Kugelberg FC; Hiemke C
Eur Neuropsychopharmacol; 2010 Sep; 20(9):632-40. PubMed ID: 20466523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
